Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Bitcoin sinks to 15-month low as a global selloff drags crypto deeper into the red

Bitcoin sinks to 15-month low as a global selloff drags crypto deeper into the red

Bitcoin fell to a 15-month low near $72,000 Wednesday amid a broad selloff, with the Nasdaq 100 down over 2%. Crypto market value dropped by $467.6 billion since Jan. 29, and $2.56 billion in bitcoin positions were liquidated in recent days. Crypto-linked stocks such as Coinbase and Gemini lost at least 15% over five sessions. Bitcoin later traded near $76,400 as some buyers returned.
4 February 2026
·····
Enact Holdings stock jumps 10% as ACT rallies on fresh buyback plan and earnings

Enact Holdings stock jumps 10% as ACT rallies on fresh buyback plan and earnings

Enact Holdings’ stock surged 10.5% to $44.58 after its board approved a new $500 million share repurchase plan, adding to an existing $350 million program. The company reported Q4 net income of $177 million and said it will maintain its $0.21 dividend, payable March 19. Genworth Holdings, which owns 81% of Enact, will sell shares back in proportion to open-market buybacks. The S&P 500 ETF fell 0.2%.
4 February 2026
·····
Amgen stock price jumps as earnings beat puts MariTide obesity bet back in focus

Amgen stock price jumps as earnings beat puts MariTide obesity bet back in focus

Amgen shares jumped 8.5% to $367.52 in afternoon trading Tuesday, outpacing a broader market decline. The company reported Q4 revenue up 9% to $9.9 billion and projected 2026 sales as high as $38.4 billion. Investors focused on late-stage trials for obesity drug MariTide. The FDA has requested withdrawal of Tavneos, but Amgen is refusing.
4 February 2026
·····
Eli Lilly stock jumps as 2026 forecast beats estimates on Zepbound, Mounjaro demand

Eli Lilly stock jumps as 2026 forecast beats estimates on Zepbound, Mounjaro demand

Eli Lilly shares surged about 9% Wednesday after reporting a 43% jump in quarterly revenue to $19.3 billion and issuing a bullish 2026 outlook. Mounjaro and Zepbound drove results, but executives warned pricing will weigh on future growth. Investors await the FDA’s April decision on Lilly’s oral obesity drug. The stock’s rally contrasted with declines in major indexes.
4 February 2026
····
Zurn Elkay stock jumps nearly 12% after outlook, cash targets catch buyers’ eye

Zurn Elkay stock jumps nearly 12% after outlook, cash targets catch buyers’ eye

Zurn Elkay Water Solutions shares jumped 11.6% to $52.52 Wednesday after reporting Q4 net sales of $407 million and adjusted earnings of 36 cents per share. Trading volume reached 1.7 million shares. The company projects mid-single digit core sales growth for 2026 and free cash flow of about $335 million. Other building-products stocks rose but lagged Zurn’s gains.
4 February 2026
·····
MGM stock jumps as BetMGM turns profitable and a surprise 8-K drops early numbers

MGM stock jumps as BetMGM turns profitable and a surprise 8-K drops early numbers

MGM shares jumped 9% to $37.30 Tuesday after BetMGM raised its outlook and reported a $270 million cash payout to owners. An SEC filing revealed MGM had accidentally posted preliminary quarterly results, showing Q4 revenue of $4.61 billion and adjusted EBITDA of $635 million. Final earnings are due Feb. 11. Caesars and Wynn also gained.
4 February 2026
····
CDW stock jumps nearly 10% after earnings beat as AI, cloud demand holds up

CDW stock jumps nearly 10% after earnings beat as AI, cloud demand holds up

CDW shares surged 9.8% to $138.53 after quarterly sales and profit topped estimates, with net sales at $5.51 billion and adjusted earnings of $2.57 per share. Gross profit rose 8.6% and small business sales jumped 18.4%. The board reaffirmed its 2026 growth target. Broader markets fell, with the Nasdaq down 1.53%.
4 February 2026
·····
Lear stock jumps 11% as Q4 results, 2026 cash-flow guide put buybacks back in focus

Lear stock jumps 11% as Q4 results, 2026 cash-flow guide put buybacks back in focus

Lear Corp shares surged 11% to $132.94 after posting a 5% rise in Q4 revenue to $6.0 billion and raising its 2026 outlook. Adjusted EPS climbed to $3.41, but free cash flow fell to $281 million. The company projects 2026 sales of up to $24.01 billion and free cash flow up to $650 million. Other auto-parts stocks also rallied, with Adient up nearly 12%.
4 February 2026
·····
Pizza Hut to Close 250 U.S. Stores as Yum’s ‘Hut Forward’ Reset Kicks In

Pizza Hut to Close 250 U.S. Stores as Yum’s ‘Hut Forward’ Reset Kicks In

Yum Brands will close about 250 underperforming Pizza Hut locations in the U.S. by mid-2026 as part of its “Hut Forward” turnaround plan. Pizza Hut’s U.S. same-store sales dropped 3% in the fourth quarter and 5% for 2025. Executives said the strategic review could lead to a sale of the chain. Pizza Hut ended 2025 with 19,974 global locations, down from 20,225 a year earlier.
4 February 2026
···
Carlisle stock jumps 11% after earnings beat and $1 billion buyback plan

Carlisle stock jumps 11% after earnings beat and $1 billion buyback plan

Carlisle Companies’ shares rose 10.7% to $394 after beating Q4 profit estimates and forecasting low single-digit revenue growth with a 0.50-point margin boost for 2026. Management expects a weak first quarter and flat second quarter, but stronger results in the second half. Q4 revenue was $1.13 billion; adjusted EPS fell to $3.90 from $4.47. The company announced up to $1 billion in buybacks for 2026.
4 February 2026
·····
Fortive stock jumps on upbeat 2026 profit view after Q4 beat, buybacks

Fortive stock jumps on upbeat 2026 profit view after Q4 beat, buybacks

Fortive shares jumped 12.4% to $61.07 after the company forecast 2026 adjusted earnings of $2.90 to $3.00 per share, topping analyst estimates. Fourth-quarter adjusted EPS reached $0.90 on $1.12 billion in revenue, with automation segment sales up 5.3%. About 8.5 million shares traded by midafternoon. Management will present at Citi and Barclays industrial conferences later this month.
4 February 2026
·····
Powell Industries stock jumps on strong profit, $1.6 billion backlog and new dividend boost

Powell Industries stock jumps on strong profit, $1.6 billion backlog and new dividend boost

Powell Industries shares jumped 14.5% to $519.02 after reporting fiscal Q1 net income of $41.4 million and revenue of $251.2 million. The company booked $439 million in new orders, closing the quarter with a $1.6 billion backlog. Powell raised its quarterly dividend to $0.27 per share, payable March 18 to shareholders on record Feb. 18.
4 February 2026
····
1 … 27 28 29 30 31 … 880

Stock Market Today

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

7 February 2026
Carvana shares rose 5.21% Friday to $403.67, rebounding after recent volatility sparked by a short-seller report from Gotham City Research. The company denied allegations of overstated earnings and undisclosed ties to DriveTime. Carvana will report Q4 and full-year 2025 results after markets close on Feb. 18. The January U.S. CPI report is scheduled for Feb. 13.
Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

7 February 2026
Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
Go toTop